Precision Proteomics Inc. (PPI) is a biotechnology company commercializing a novel proteomics platform for basic, pre-clinical and clinical .
Services
Our Services

Ultra-deep and Quantitative
Phosphoproteomics by SH2S-MS
Discovery Tyr phosphoproteomics with unparalleled depth and breadth enabled by our SH2S AP-MS/MS pipeline, Complete phosphoproteomics (pY/pS/pT) by sequential SH2S and IMAC enrichment followed by MS/MS ,Quantitative proteomics and phosphoproteomics via isobaric labelling (eg., TMT)

Ultra High-Resolution Phosphoproteomics Empowered by the SH2S Technology
PPI’s core technology- the SH2 Superbinder, when combined with mass spectrometry, enables direct, systematic and quantitative profiling of protein kinase and immune signaling with exceptional sensitivity and at unprecedented resolution

Oncology and Immuno-Oncology –Pre-clinical and Clinical
Drug target and biomarker discovery, Drug screening and PD investigations, Subgroup analysis of trial readouts, Companion & molecular diagnostic development, Development strategy for combo therapies.